Human Factors Validation of a Pegcetacoplan On-Body Injector Demonstrates Ease of Use by Adolescents with C3 Glomerulopathy/Primary Immune-Complex Membranoproliferative Glomerulonephritis
Year: 2025
Type: article
Authors: Eliyahu V. Khankin, Chirayu Mehta, Chauncey Clemons
Institution: Apellis Pharmaceuticals (United States)
Language: English
Subfield: Emergency Medical Services
Field: Health Professions
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7104531414
FWCI:
Cites:
Cited by:
Related to:
